Insights

Home > Insights >

Press Releases

2025-10-13
How to Choose the Precision AAV Tools for Your Cardiovascular Research?
2025-06-26
FDA Acceptance of Drug Master File Marks New Milestone Achieved for OBiO TECH of GMP Plasmid Products
2023-06-29
FDA Acceptance of Drug Master File Marks New Milestone Achieved for OBiO TECH of GMP Plasmid Products
OBiO Technology (Shanghai) Corp., Ltd('OBiO', 688238. SH) is a biotechnology company focusing on the cell and genetherapy field. Recently announced that the U.S. Food and Drug Administration(FDA)
ALL PRESS RELEASES
Events
Nov. 15-19, 2025
SfN Neuroscience 2025
San Diego
Nov. 7-10, 2025
AHA 2025 American Heart Association
New Orleans, LA
Nov. 6, 2025
ACRE@AHA
New Orleans, LA
May 16-20, 2023
ASGCT 26TH ANNUAL MEETING
Los Angeles, CA
May 16-20, 2023
ASGCT 26TH ANNUAL MEETING_copy
Los Angeles, CA
JUL 15-16, 2022
China Oncolytic Virus Conference 2022 (Hybrid)
SHANGHAI, China

Inquiry

CDMO Solutions


scientific services

Request Now
© OBiO Tech, Inc. All Rights Reserved